Expression of Acetylcholine Receptor Genes in Human Thymic Epithelial Cells: Implications for Myasthenia Gravis

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3752-3760

  Wakkach, Abdelilah ^a   Guyon, Thierry ^a   Bruand, Corinne ^a   Tzartos, Socrates ^b   Cohen Kaminsky, Sylvia ^a   Berrih Aknin, Sonia ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; MESSENGER RNA; PRIMER DNA;

ADOLESCENT; ADULT; ARTICLE; CELL CULTURE; CHILD; CYTOLOGY; EPITHELIUM; EPITHELIUM CELL; GENE EXPRESSION; GENETICS; HUMAN; IN VITRO STUDY; INFANT; METABOLISM; MIDDLE AGED; MUSCLE; MYASTHENIA GRAVIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; THYMUS;

ADOLESCENT; ADULT; BASE SEQUENCE; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; EPITHELIAL CELLS; EPITHELIUM; GENE EXPRESSION; HUMANS; INFANT; MIDDLE AGED; MUSCLES; MYASTHENIA GRAVIS; POLYMERASE CHAIN REACTION; RECEPTORS, CHOLINERGIC; RNA, MESSENGER; THYMUS GLAND;

EID: 0030587964     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Lindstrom, J. M., M. L. Seybold, V. A. Lennon, S. Whittingham, and D. D. Duane. 1976. Antibody to acetylcholine receptor in MG: prevalence, clinical correlates and diagnostic value. Neurology 26:1054.
2. Berrih-Aknin, S., E. Morel, F. Raimond, D. Safar, C. Gaud, J. P. Binet, P. Levasseur, and J. F. Bach. 1987. The role of the thymus in myasthenia gravis. Immunohistological and immunological studies in 115 cases. In Myasthenia Gravis: Biology and Treatment. D. B. Drachman, ed. Ann. NY Acad. Sci 505:50.
3. Le Brigand, H., P. Levasseur, A. R. Miranda, C. Gaud, and I. Wojakowski. 1980. Surgical treatment of myasthenia gravis by thymectomy: a report on 248 cases. Ann. Chir. 34:169.
4. Cohen-Kaminsky, S., P. Levasseur, J. P. Binet, and S. Berrih-Aknin. 1989. Evidence of enhanced recombinant interleukin-2 sensitivity in thymic lymphocytes from patients with myasthenia gravis: possible role in the autoimmune pathogenesis. J. Neuroimmunol. 24:75.
5. Leprince, C., S. Cohen-Kaminsky, S. Berrih-Aknin, B. Vernet der Garabedian, D. Treton, P. Galanaud, and Y. Richard. 1990. Thymic B cells from Myasthenia Gravis (MG) patients are activated B cells: phenotypic and functional analysis. J. Immunol. 145:2115.
6. Popot, J. L., and J. P. Changeux. 1984. The nicotinic receptor of acetylcholine structure of an oligomeric integral membrane protein. Physiol. Rev. 64:1162.
7. Mamalaki, A., and S. Tzartos. 1994. Nicotinic acetylcholine receptor: structure, function and main immunogenic region. Adv. Neuroimmunol. 4:339.
8. Mishina, M., T. Takai, K. Imoto, M. Noda, T. Takahashi, and S. Numa. 1986. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 321:406.
9. Tzartos, S. J., and J. P. Changeux. 1983. High affinity binding of α Bungarotoxin to the purified Q subunit and to its 27000 dalton proteolytic peptide from Torpedo Marmorata acetylcholine receptor. Requirement for sodium dodecyl sulfate. EMBO J. 2:381.
10. Tzartos, S. J., M. E. Seybold, and J. Lindstrom. 1989. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 79:188.
11. Barkas, S., J. M. Gabriel, A. Mauron, J. Hughes, B. Roth, C. Alliod, S. Tzartos, and M. Ballivet. 1988. Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor bind to residues 61-76 of the α-subunit. J. Biol. Chem. 263:5916.
12. Beeson, D., A. Morris, A. Vincent, and J. Newsom-Davis. 1990. c. The human muscle nicotinic acetylcholine receptor alpha-subunit exists as two isoforms: a novel exon. EMBO J. 9:2101.
13. Engel, W. K., J. L. Trotter, D. E. McFarlin, and C. L. McIntosh. 1977. Thymic epithelial cell contains acetylcholine receptor. Lancet I:1310.
14. Fuchs, S., I. Schmidt-Hopfeld, G. Tridente, and R. Tarrab-Hazdai. 1980. Thymic lymphocytes bear a surface antigen which cross-reacts with acetylcholine receptor. Nature 287:162.
15. Schluep, M., N. Willcox, A. Vincent, G. K. Dhoot, and J. Newsom-Davis. 1987. Acetylcholine in human thymic myoid cells in situ: an immunologic study. Ann. Neurol. 22:212.
16. Kao. I., and D. B. Drachman. 1978. Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science 195:74.
17. Geuder, K. I. R., R. Schoepfer, T. Kirchner, A. Marx, and H. K. Muller-Hermelink. 1989. The gene of the a-subunit of the acetylcholine receptor: molecular organization and transcription in myasthenia-associated thymomas. Thymus 14:179.
18. Hara, Y., S. Ueno, T. Uemichi, N. Takahashi, S. Yorifuji, Y. Fujii, and S. Tarui. 1991. Neoplastic epithelial cells express α-subunit of muscle nicotinic acetylcholine receptor in thymomas from patients with myasthenia gravis. FEBS Lett. 279:137.
19. Talib, S., T. B. Okarma, and J. S. Lebkowski. 1993. Differential expression of human nicotinic acetylcholine receptor α subunit variants in muscle and non-muscle tissues. Nucleic Adda Res. 21:233.
20. Hara, H., K. Hayashi, K. Ohta, N. Itoh, and M. Ohta. 1993. Nicotinic acetylcholine receptor mRNAs in myasthenic thymuses. Biochem. Biophys. Res. Commun. 194:1269.
21. Kaminski, H. J., R. A. F. Fenstermaker, W. Abdul-Karim, J. Clayman, and R. L. Ruff. 1993. Acetylcholine receptor subunit gene expression in thymic tissue. Muscle Nerve 16:1332.
22. Berrih-Aknin, S., F. Arenzana-Seisdedos, S. Cohen, R. Devos, D. Charron, and J. L. Virelizier. 1985. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells. J. Immunol. 35:1165.
23. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
24. Guyon, T., P. Levasseur, F. Truffault, C. Cottin, C. Gaud, and S. Berrih-Aknin. 1994. Regulation of acetylcholine receptor a subunit variants in human myasthenia gravis: quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction. J. Clin. Invest. 94:16.
25. Papadouli, I., C. Sakarellos, and S. J. Tzartos. 1993. High-resolution epitope mapping and fine antigenic characterization of the main immunogenic region of the acetylcholine receptor. Improving the binding activity of synthetic analogues of the region. Eur. J. Biochem. 211:227.
26. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 15:680.
27. Tzartos, S. J., and M. S. Remoundos. 1992. Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acelylcholine receptor α subunit. Eur. J. Biochem. 207:915.
28. Conroy, W. G., M. S. Saedi, and J. Lindstrom. 1990. TE671 cells express an abundance of a partially mature acetylcholine receptor a-subunit which has characteristics of an assembly intermediate. J. Biol. Chem. 265:21642.
29. Seaman, K., W. Padgett, and J. Daly. 1981. Forskolin: unique diterpene activator of adenylate cyclase in membranes and intact cells. Proc. Natl. Acad. Sci. USA 6:3363.
30. Grassi, F., L. Monaco, and F. Eusebi. 1987. Acetylcholine receptor channel properties in rat myotubes exposed to forskolin. Biochem. Biophys. Res. Commun. 147:1000.
31. Luther, M. A., R. Schoepfer, P. Whiting, B. Casey, Y. Blatt, M. S. Montal, M. Montal, and J. Lindstrom. 1989. A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671. J. Neurosci. 9: 1082.
32. Marx, A., T. Kirchner, F. Hoppe, R. O'Conner, B. Schalke, S. Tzarlos, and H. K. Muller-Hermelink. 1989. Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis. Am. J. Pathol. 134: 865.
33. Marx, A., R. O'Connor, K. I. Geuder, F. Hoppe, B. Schalke, S. Tzartos, I. Kalies, T. Kirchner, and H. K. Muller-Hermelink. 1990. Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab. Invest. 62:279.
34. Wheatley, L. M., D. Urso, K. Tumas, J. Maltzman, E. Loh, and A. I. Levinson. 1992. Molecular evidence for the expression of nicotinic acetylcholine receptor alpha-chain in mouse thymus. J. Immunol. 148:3105.
35. Nelson, S., and B. M. Conti-Tronconi. 1990. Adult thymus expresses an embryonic nicotinic acetylcholine receptor-like protein. J. Neuroimmunol. 29:81.
36. Klarsfeld, A., and J. P. Changeux. 1985. Activity regulates the level of acetylcholine receptor alpha-subunit mRNA in cultured chick myotubes. Proc. Natl. Acad. Sci. USA 82:4558.
37. Miles, K., D. Anthony, L. Rubin, P. Greengard, and R. Huganir. 1987. Regulation of nicotinic acelylcholine receptor phosphorylation in rat myotubes by forskolin and cAMP. Proc. Natl. Acad. Sci. USA 84:6591.
38. Albuquerque, E., S. Deshpande, V. Aracawa, M. Alkondon, and J. Daly. 1986. A possible involvement of cyclic AMP in the expression of desensitization of the nicotinic acetylcholine receptor. A study with forskolin and its analogs. FEBS Lett. 199:113..
39. Savino, W., and M. Dardenne. 1995. Immune-neuroendocrine interactions. Immunol. Today 16:318.
40. Al-Shawaf, A. A., M. D. Kendall, and T. Cowen. 1991. Identification of neural profiles containing vasoactive intestinal polypeptide, acetylcholinesterase and catecholamines in the rat thymus. J. Anat. 174:131.
41. Plaut, M. 1987. Lymphocyte hormone receptors. Ann. Rev. Immunol. 5:621-669.
42. Rinner, I., T. Kukulansky, P. Felsner, E. Skreiner, A. Globerson, M. Kasai, K. Hirokawa, W. Korsatko, and K. Schauenstein. 1994. Cholinergic stimulation modulates apoptosis and differentiation of murine thymocytes via a nicotinic effect on thymic epithelium. Biochem. Biophys. Res. Commun. 203:1057.
43. Tominaga, K., Y. Kinoshita, F. Hato, A. Masuda, and M. Matsuyama. 1989. Effects of cholinergic agonists on the proliferation and protein synthesis in a cultured thymic epithelial cell line. Cell. Mol. Biol. 35:679.
44. Tria, M. A., G. Vantini, M. G. Fiori, and A. Rossi. 1992. Choline acetyltransferase activity in murine thymus. J. Neurosci. Res. 31:380.
45. Busch, R., and E. D. Mellins. 1996. Developing and shedding inhibitions: how MHC class II molecules reach maturity. Curr. Opin. Immunol. 8:51.
46. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84: 543.
47. Iwabuchi, K., K. I. Nakayama, R. L. McCoy, F. Wang, T. Nishimura, S. Habu, K. M. Murphy, and D. Y. Loh. 1992. Cellular and peptide requirements for in vitro clonal deletion of immature thymocytes. Proc. Natl. Acad. Sci. USA: 9000.
48. Oehen, S. U., P. S. Ohashi, K. Bürki, H. Hengartner, R. M. Zinkernagel, and P. Aichele. 1994. Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels. Cell. Immunol. 158:342.
49. Ohashi, P. S., S. Oehen, K. Bürki, H. Pircher, C. T. Ohashi, B. Odermatt, B. Malissen, R. M. Zinkernagel, and H. Hengartner. 1991. Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:304.
50. Jermy, A., D. Beeson, and A. Vincent. 1993. Pathogenic autoimmunity to affinity-purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice. Eur. J. Immunol. 23:973.
51. Sommer, N., G. C. Harcourt, N. Willcox, D. Beeson, and J. Newsom-Davis. 1991. acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Neurology 41:1270.
52. Melms, A., G. Malcherek, U. Gern, H. Wietholer, C. A. Muller, R. Schoepfer, and J. Lindstrom. 1992. T cells from normal and myasthenic individuals recognize the human acetylcholine: heterogeneity of antigenic sites on the alpha-subunit. Ann. Neurol. 87:2191.